Yi‐Ming Lin, Ai‐Yong Cui, Da‐Wei Wang, Hua‐Ding Lu – 14 November 2020

Mussarat N. Rahim, Shaolu Ran, Sital Shah, Sarah Hughes, Michael A. Heneghan – 14 November 2020

Samuel J. Kesseli, Mariya L. Samoylova, John Yerxa, Carrie B. Moore, Marcelo Cerullo, Qimeng Gao, Nader Abraham, Yuval A. Patel, Lisa M. McElroy, Deepak Vikraman, Andrew S. Barbas – 14 November 2020 – Liver grafts from pediatric donors represent a small fraction of grafts transplanted into adult recipients, and their use in adults requires special consideration of donor size to prevent perioperative complications.

The 2020 Hans Popper lecture reviews the cellular and molecular mechanisms of liver regeneration upon toxic injury, and how these mechanisms change in disease, mainly cancer. Learn how one lab combined animal and human organoid models, how to recapitulate key aspects of liver development and regeneration in vitro, and potential applications of these models in personalized medicine.

At this symposium, experts explore current controversies in transplant hepatology. An ethicist sets the stage with a lively discussion of current practices and challenges in patient and organ selection. Questions explored will include strategies to increase the donor pool, including living and altruistic donations, and the role of transplantation in patients with high-risk liver tumors and underlying mitochondrial disease.

Join this year's Career Development Workshop designed for both trainees interested in a hepatology career and early-career hepatologists. Participants will explore hepatology training pathways to different career opportunities, ranging from research to community-based practice. Participants will discuss the rewards and challenges of various careers, and strategies to maximize one’s potential, including finding mentors.

What role does social media, the communications landscape that currently influences everything from politics to pop culture, play in hepatology and healthcare? This program will expose participants to different aspects of social media and encourage discussion ways that social media could advance the science and practice of hepatology.

Alcohol-associated liver disease (ALD) has emerged as a leading indicator of liver disease and the need for organ transplant. Currently, we lack effective pharmacological therapies to improve long-term outcomes in ALD patients, but new research advances are highly encouraging. Join this ALD SIG program for important research updates and to identify unmet clinical needs in ALD patients.

Value-based Arrangements are an increasingly expanding and necessary part of the U.S. healthcare landscape. This program will educate and empower hepatologists to be valuable contributors to the success of these new arrangements and play an active role in developing and implementing beneficial approaches for all patients with liver disease.

What is the role of organ transplantation in the care of acute on chronic liver failure (ACLF)? This program was designed to thoroughly review the management of the ACLF patient awaiting liver transplantation (LT), and to examine recently published data on patient outcomes. Post-LT complications and the evolving role of palliative care in patients listed for LT will be explored.